Carlos Milla
Publication Details
-
Insulin glargine improves hemoglobin A1c in children and adolescents with poorly controlled type 1 diabetes.
Pediatr Diabetes. 2003; (2): 64-9
The pediatric diabetes team at the University of Minnesota made a clinical decision to switch patients with type 1 diabetes with a hemoglobin A1c level greater than 8.0% to insulin glargine in an effort to improve glycemic control. Retrospective chart analysis was performed on 37 patients 6 months after the switch to insulin glargine therapy.
